“…Delightedly, the corresponding products ( 3x - 3z, 3aa-3ac ) were obtained in good to excellent yields with good functional group tolerance. In addition, given the prevailing existence of amines in pharmaceutical molecules and natural products (Ma et al., 2018a, Brunet and Neibecker, 2001), we selected Benzocaine ( 1ad , local anesthetic), Amoxapine ( 2ae , antidepressant), 2-(piperazin-1-yl)-4-(trifluoromethyl)pyrimidine ( 2af , medical/material intermediates), and multi-functional Vildagliptin ( 2ag , inhibit glucagon/chiral reagent/medicinalintermediate) and exposed them under the standard conditions; the corresponding products were obtained in 59%, 76%, 61%, and 71% yields, respectively. Gratifyingly, the chiral molecule ( S )- N -benzyl-1-phenylethan-1-amine ( 2ah ) experienced the optimal reaction conditions to deliver ( S , E )- N -benzyl- N′ -phenyl- N -(1-phenylethyl)formimidamide ( 3ah ) in 60% yield, which might be a potential chiral ligand to realize enantioselective-control reactions.…”